An article last month on the Nautilus website posed an interesting question: “Why is Biomedical Research So Conservative?” Possible answers were summed up in the sub-headline: “Funding, incentives, and scepticism of theory make some scientists play it safe.” This is not to say that there is insufficient imagination going into the research application of advances in machine learning and data management in improving health outcomes. In fact, another article came out about the same time on the Fast Company website, discussing “How Artificial Intelligence is Bringing us Smarter Medicine”. It distinguished a host of impressive advances under five significant headings: drug creation, diagnosing disease, medication management, health assistance, and precision medicine.
People could say ah yes: well, that’s machine smarts at the applied rather than the theoretical end of medical research, although that is less true in the first and last of these categories: supercomputers are very much engaged in the analysis of molecular structures from which it is hoped new therapies will emerge, and in the vast data sets which are being created within the science of genomics as we move into a new era of precision, personalised medicine.
Nevertheless, it does seem that pure research in biology – as distinct from physics – has been playing it comparatively safe, and the Nautilus article provides the evidence for its ruminations. Natural language processing analysis of no fewer than two million research papers, and 300,000 patents arising from work with 30,000 molecules, showed a remarkable bias towards conditions common in the developed world and with an emphasis on areas where the research roads are already well travelled – predominantly in cancer and heart disease.
My own communications work in the dementia environment – specifically Alzheimer’s disease – suggests that another reason may be in play. Where medical research has been less conservative, more adventurous, and broadly more successful, there has been more collaboration and shared excitement around a commonly perceived mission. The more open-source, zealous, and entrepreneurial eco-system that has applied for decades in heart and in cancer research – and we see this now on steroids in the field of artificial intelligence developments – has yet to capture the imagination of the wider biomedical community, where the approach remains generally more careful, more academic and inward-looking: just, more conservative.
Lively Stuff from Planet BAM!
- Code of Ethics proposed for human augmentation
Lots of work is being done on the foothills of AI ethics, particularly in the areas of privacy of data and the dynamics of surveillance, i.e. if they watch us, that may be fine if we can watch them back. All of this keen thinking needs to make an impact at the highest level of national and international governing bodies.
- Will the robots be asking: Where did everybody go?
An alarming report out of London’s Imperial College warns of a possible biodiversity crisis. What happens if so many species become extinct that the earth’s eco-system degrades to a point beyond which human society becomes unsustainable?
- How to be a grandmaster at Machiavellian chess
An article in Psychology Today reflects on deception and betrayal in the UK’s Tory party, comparing Michael Gove’s machinations to a game of chess. It may be chess, but not as Deep Mind knows it. And as to the articles’s sub-headed wondering what the whole sorry affair might “teach us about ourselves”, the story seems to be far less about chess and more about karma: Michael Who?